RECURRENT MEDULLOBLASTOMA
Clinical trials for RECURRENT MEDULLOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MEDULLOBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT MEDULLOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough brain cancers: immune cell therapy trial opens
Disease control Recruiting nowThis early-stage trial is testing a new cell therapy for children and young adults with aggressive brain tumors that have come back or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target a protein (GPC2) on the t…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for kids with deadly brain cancers: experimental vaccine trial opens
Disease control Recruiting nowThis study is testing a new vaccine designed to train the immune system to fight aggressive brain cancers in children and young adults. It will enroll about 120 patients aged 3 to 39 with newly diagnosed high-grade glioma, diffuse intrinsic pontine glioma (DIPG), or recurrent med…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Targeted radiation attack on tough brain tumors in kids
Disease control Recruiting nowThis study is testing a drug called Lutathera in children and young adults (ages 4 to 39) with aggressive brain or spinal cord tumors that have come back or gotten worse after standard treatments. Lutathera is a targeted radiation therapy that seeks out and attaches to specific m…
Matched conditions: RECURRENT MEDULLOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC